Unique ID issued by UMIN | UMIN000043006 |
---|---|
Receipt number | R000049087 |
Scientific Title | A Study on the Effect of Plant-Derived Products on gut microbiome -A Randomized, Double-blind, Placebo-controlled, Parallel-group Study- |
Date of disclosure of the study information | 2021/01/22 |
Last modified on | 2021/12/24 15:56:34 |
A Study on the Effect of Plant-Derived Products on gut microbiome
-A Randomized, Double-blind, Placebo-controlled, Parallel-group Study-
A Study on the Effect of Plant-Derived Products on gut microbiome
A Study on the Effect of Plant-Derived Products on gut microbiome
-A Randomized, Double-blind, Placebo-controlled, Parallel-group Study-
A Study on the Effect of Plant-Derived Products on gut microbiome
Japan |
No
Adult |
Others
NO
To confirm the effect of plant-derived products on gut microbiome
Efficacy
gut microbiome
Defecation questionnaire, Conditioning questionnaire
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Treatment
Food |
Plant-Derived Products, 4 weeks consumption
Placebo Products, 4 weeks consumption
20 | years-old | <= |
65 | years-old | > |
Male and Female
(1)Healthy males and females aged 20 to 64 years-old who defecate three to five a week.
(2)Subjects who do not habitually consume a large amounts of alcohol.
(3)Subjects who regularly eat three meals a day.
(4)Subjects who can make self-judgment and are voluntarily giving written informed consent.
Subjects (who)
(1)regularly use intestinal and constipation drugs (including laxatives).
(2)can't stop intake food containing viable bacteria such as Lactic acid bacteria, Bifidobacteria, Natto bacteria and/or enhanced with oligosaccharide, dietary fiber and/or the health food to relieve constipation (including Food for Specified Health Uses or Foods with Function Claims) and/or containing a large amount of sugar alcohol during this study.
(3)regularly eat foods containing lactic acid bacteria, bifidobacteria, and/or oligosaccharides to relieve constipation.
(4)used antibiotics within the last 2 weeks prior to the screening.
(5)have a history and/or a surgical history of digestive disease affecting digestion and absorption.
(6)have been diagnosed irritable bowel syndrome or inflammatory bowel disease.
(7)have any food allergies.
(8)have excessive alcohol intake more than approximately 20 g / day of pure alcohol equivalent or habit of drinking more than 4 days a week.
(9)can't stop drinking from 2 days before each measurement.
(10)are shiftworker and/or midnight-shift worker.
(11)contract or are under treatment for serious diseases (e.g., liver disease, kidney disease, digestive disease, heart disease, respiratory disease, endocrine disease, thyroid disease, adrenal disease and/or metabolic disease).
(12)with greatly disturbed menstrual cycle.
(13)plan to become pregnant after informed consent, pregnant or lactating.
(14)have donated over 200 mL of blood and/or blood components within the last 1 month or over 400 mL of blood and/or blood components within the last 3 months prior to the study.
(15)are under treatment for or have a history of drug addiction and/or alcoholism.
(16)plan to participate in other clinical studies during test periods and/or had participated in other clinical studies within the last one month.
(17)are judged unsuitable for the study by the screening.
(18)are judged unsuitable for the study by the investigator for other reasons.
60
1st name | Yoshitaka |
Middle name | |
Last name | Iwama |
Nihonbashi Cardiology Clinic
Director
103-0001
Kyodo Bldg. #201, 13 - 4 Nihonbashi Kodenmacho, Chuo-ku, Tokyo
03-5641-4133
yiwama@well-sleep.jp
1st name | Yoshika |
Middle name | |
Last name | Komori |
KSO Corporation
Sales department
105-0023
1-9-7 Shibaura, Minato-ku, Tokyo
03-3452-7733
yoshi@kso.co.jp
KSO Corporation
TOYO SHINYAKU Co., Ltd.
Profit organization
Ethical Committee of Nihonbashi Cardiology Clinic
Kyodo Bldg. #201, 13 - 4 Nihonbashi Kodenmacho, Chuo-ku, Tokyo
03-5641-4133
niho-jimucho@well-sleep.jp
NO
2021 | Year | 01 | Month | 22 | Day |
https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000049087
Published
http://www.pieronline.jp/content/article/0386-3603/49100/1681
60
Statistically significant difference was confirmed in the primary outcome.
2021 | Year | 12 | Month | 24 | Day |
Males and females aged 20 to 64 years old.
Enrolled(n=60)
Completed(n=60)
Analysed(n=55)
No adverse events were observed that be related to test food.
gut microbiome
Main results already published
2020 | Year | 12 | Month | 08 | Day |
2020 | Year | 12 | Month | 14 | Day |
2021 | Year | 01 | Month | 23 | Day |
2021 | Year | 03 | Month | 27 | Day |
2021 | Year | 01 | Month | 15 | Day |
2021 | Year | 12 | Month | 24 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049087
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |